Bryan Patterson(@bryanpatterso20) 's Twitter Profile Photo

I just signed ProstateCancerResearch' petition calling for major political parties to commit to a national prostate cancer screening programme. No one should be dying from this disease. Join me and add your name! act.prostate-cancer-research.org.uk/a/manifestos?u…

account_circle
Institute of Oncology Research (IOR)(@IOR_Bellinzona) 's Twitter Profile Photo


New study led by IOR, in collaboration with the Veneto Institute of Molecular Medicine (VIMM) and the University of Padua identifies a promising new treatment for , detailed in a recent publication on Cancer Cell.

👉Read the news: shorturl.at/gntEH

account_circle
ProstateUK Profs(@ProstateUKProfs) 's Twitter Profile Photo

Fantastic to see Priyanka P present the results of the Prostate Cancer UK funded TRAP trial at

The team The ICR found by combining radiotherapy with hormone therapy, some men with advanced can avoid chemotherapy

📖 Read more: bit.ly/4aYJDfr

Fantastic to see @Priyankapetal present the results of the @ProstateUK funded TRAP trial at #ESTRO2024

The team @ICR_London found by combining radiotherapy with hormone therapy, some men with advanced #prostatecancer can avoid chemotherapy

📖 Read more: bit.ly/4aYJDfr
account_circle
Priyamvada Maitre(@docpriyamvada) 's Twitter Profile Photo

symposium: Optimising TARGET🎯 by Dr Floris Pos
👉FLAME RCT: ⬆️GTV dose better
👉minimum (D98%) GTV dose more imp than mean (D50%), prefer >=90Gy
👉⬆️Gleason needs ⬆️dose

#ESTRO2024 #prostatecancer symposium: Optimising TARGET🎯 by Dr Floris Pos
👉FLAME RCT: ⬆️GTV dose better
👉minimum (D98%) GTV dose more imp than mean (D50%), prefer >=90Gy
👉⬆️Gleason needs ⬆️dose
account_circle
Breen & Pugh Law(@BreenPugh) 's Twitter Profile Photo

10 days out! Help us in the fight against . I'm riding in The Distinguished Gentleman's Ride on Sunday 19th May 2024. Support me and my motorcycle in raising funds and awareness for prostate cancer and men's mental health. gentlemansride.com/s/74804/183465…

account_circle
Perlmutter Cancer Center at NYU Langone Health(@Perlmutter_CC) 's Twitter Profile Photo

The largest five-year oncological outcomes study for primary partial gland reveals a 91% freedom-from-failure rate in intermediate-risk .

Learn more with study investigators Drs. Herbert Lepor and James Wysock: bit.ly/3WomkHh

The largest five-year oncological outcomes study for primary partial gland #cryoablation reveals a 91% freedom-from-failure rate in intermediate-risk #prostatecancer.

Learn more with study investigators Drs. Herbert Lepor and James Wysock: bit.ly/3WomkHh
account_circle
OncoAlert(@OncoAlert) 's Twitter Profile Photo

The OncoAlert🚨NEWSLETTER OUT
Covering May 2-8, 2024

REGISTER at OncoAlert360.com OR oncoalert.m-pages.com/nhMpwe/oncoale…

The Lancet Commission on
✅DESTINY-PanTumor01
✅Osimertinib+Local tx for brain🧠mets in EGFRm 🫁
✅ASCENT in Triple Negative…

account_circle
Laser Stones Clinic(@LaserStones) 's Twitter Profile Photo

प्रोस्टेट कैंसर क्या है?
-
𝐂𝐨𝐧𝐬𝐮𝐥𝐭 𝐰𝐢𝐭𝐡 𝐃𝐫.𝐕𝐢𝐩𝐢𝐧 𝐒𝐢𝐬𝐨𝐝𝐢𝐚 & 𝐃𝐫.𝐃𝐞𝐯𝐞𝐧𝐝𝐫𝐚 𝐊𝐮𝐦𝐚𝐫 𝐁𝐚𝐛𝐛𝐚𝐫 (𝐁𝐞𝐬𝐭 𝐔𝐫𝐨𝐥𝐨𝐠𝐢𝐬𝐭 𝐢𝐧 𝐆𝐫𝐞𝐚𝐭𝐞𝐫 𝐍𝐨𝐢𝐝𝐚).

☎️Contact us:-(+91)9990509314,(+91)9843022153.

प्रोस्टेट कैंसर क्या है?
-
𝐂𝐨𝐧𝐬𝐮𝐥𝐭 𝐰𝐢𝐭𝐡 𝐃𝐫.𝐕𝐢𝐩𝐢𝐧 𝐒𝐢𝐬𝐨𝐝𝐢𝐚 & 𝐃𝐫.𝐃𝐞𝐯𝐞𝐧𝐝𝐫𝐚 𝐊𝐮𝐦𝐚𝐫 𝐁𝐚𝐛𝐛𝐚𝐫 (𝐁𝐞𝐬𝐭 𝐔𝐫𝐨𝐥𝐨𝐠𝐢𝐬𝐭 𝐢𝐧 𝐆𝐫𝐞𝐚𝐭𝐞𝐫 𝐍𝐨𝐢𝐝𝐚).

☎️Contact us:-(+91)9990509314,(+91)9843022153.

#prostatecancer #DrVipinSisodia
account_circle
Priyamvada Maitre(@docpriyamvada) 's Twitter Profile Photo

weekly in IR-earlyHR : HYPO-FLAME trial
👉75% EAU high risk
👉prostate 35/5, GTV (MRI) upto 50/5🫨
👉5y bDFS 93% despite no ADT in 38%!!🤩
👉late tox ONLY 1-2% gr3 😊
👏🏼👏🏼

#SBRT weekly in IR-earlyHR #prostatecancer: HYPO-FLAME trial #ESTRO2024
👉75% EAU high risk
👉prostate 35/5, GTV (MRI) upto 50/5🫨
👉5y bDFS 93% despite no ADT in 38%!!🤩
👉late tox ONLY 1-2% gr3 😊
👏🏼👏🏼
account_circle